Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study
Authors:
- Khalid AbouGalalaKAKhalid AbouGalala
- Basant ElsayedBEBasant Elsayed
- Mohamed ElmarasiMEMohamed Elmarasi
- Mona KotobMKMona Kotob
- Reham TahaRTReham Taha
- Fardous AbbasherFAFardous Abbasher
- Ahmed AmarahAAAhmed Amarah
- Mariam El HamawiMHMariam El Hamawi
- Soha S. AlbayatSASoha S. Albayat
- Jazeel AbdulmajeedJAJazeel Abdulmajeed
- Mohamed A. H. SallamMSMohamed A. H. Sallam
- Maha H. M. Al-ShamaliMAMaha H. M. Al-Shamali
Open Access
- 20 February 2023
- journal article
- research article
- Published by MDPI AG in Microbiology Research
- Vol. 14 (1) , 289-296
Abstract
This study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar.Keywords
Funding Information
- Ministry of Public Health (MoPH) in Qatar
This publication has 20 references indexed in Scilit:
- Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regressionJournal of Stroke and Cerebrovascular Diseases, 2020
- The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 SubjectsJournal of the American Medical Directors Association, 2020
- Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysisDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- COVID-19 and neuromuscular disordersNeurology, 2020
- Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysisJournal of Medical Virology, 2020
- Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-AnalysisTropical Medicine and Infectious Disease, 2020
- Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-AnalysisPreprints.org, 2020
- Diabetes in the Middle-East and North Africa: An updateDiabetes Research and Clinical Practice, 2014
- Neuromuscular disease and respiratory failurePractical Neurology, 2008
- Genetic disorders in the Arab worldBMJ, 2006